Literature DB >> 28708785

Y Box-Binding Protein 1 Promotes Epithelial-Mesenchymal Transition, Invasion, and Metastasis of Cervical Cancer via Enhancing the Expressions of Snail.

Tianyun Pang1, Min Li, Ye Zhang, Weiwei Yong, Haixian Kang, Yunhong Yao, Xinrong Hu.   

Abstract

OBJECTIVE: Y box-binding protein 1 (YB-1) is a potent oncogenic protein. How it regulates Snail in most tumors including cervical cancer is unknown. This article is to study if YB-1 plays a role in cervical cancer via regulating the expression of Snail.
METHODS: Immunohistochemical staining of YB-1, Snail, and E-cadherin (E-cad) was performed on tissue specimens including 35 cases of chronic cervicitis (as a control), 35 cases of cervical intraepithelial neoplasm (CIN) I, 35 cases of CIN II/III, 28 cases of unmetastatic cervical squamous cell carcinoma, and 19 cases of metastatic cervical squamous cell carcinoma. RNA interference technique was used to knock down YB-1, E6, and Snail genes. Quantitative polymerase chain reaction, western blot, and transwell experiment were used to detect RNA, protein, and cell invasion of cervical cancer cell lines Hela and C33A, respectively.
RESULTS: First, YB-1 knockdown significantly reduced messenger RNA (mRNA) and protein levels of Snail, followed by the increased mRNA and protein levels of E-cad and the decreased invasive ability in both Hela (human papillomavirus [HPV] 18+) and C33A (HPV-) cell lines. Second, YB-1 and Snail protein were correlatively expressed in the group order of metastatic cervical squamous cell carcinoma > unmetastatic cervical squamous cell carcinoma > CINs > cervicitis, with the inverse expression mode of E-cad in the group order, P value less than 0.01, between any 2 groups. Finally, HPV18 E6 knockdown reduced the mRNA and protein levels of YB-1 and Snail in Hela cells.
CONCLUSIONS: The results firstly reported that YB-1 whose mRNA expression is regulated by HPV18 E6 promotes epithelial-mesenchymal transition and progression of cervical cancer via enhancing the expressions of Snail, which indicated that YB-1/Snail/epithelial-mesenchymal transition axis could have a potential use in the diagnosis and therapy of cervical cancer metastasis as a cancer marker and molecular target.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28708785     DOI: 10.1097/IGC.0000000000001066

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Quantitative Proteomic Analysis of Cervical Cancer Tissues Identifies Proteins Associated With Cancer Progression.

Authors:  Alberto Ramírez-Torres; Jeovanis Gil; Sandra Contreras; Graciela Ramírez; Heriberto A Valencia-González; Emmanuel Salazar-Bustamante; Leopoldo Gómez-Caudillo; Alejandro García-Carranca; Sergio Encarnación-Guevara
Journal:  Cancer Genomics Proteomics       Date:  2022 Mar-Apr       Impact factor: 4.069

Review 2.  Meta-analysis of downregulated E-cadherin as a diagnostic biomarker for cervical cancer.

Authors:  Xiaoxia Ma; An Ge; Jie Han; Jin Kang; Yating Zhang; Xiaohong Liu; Li Xing; Xiaochun Liu; Li Dong
Journal:  Arch Gynecol Obstet       Date:  2022-03-13       Impact factor: 2.344

3.  YB1 associates with oncogenetic roles and poor prognosis in nasopharyngeal carcinoma.

Authors:  Yuting Zhan; Xianyong Chen; Hongmei Zheng; Jiadi Luo; Yang Yang; Yue Ning; Haihua Wang; Yuting Zhang; Ming Zhou; Weiyuan Wang; Songqing Fan
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

4.  Combined Snail and E-cadherin Predicts Overall Survival of Cervical Carcinoma Patients: Comparison Among Various Epithelial-Mesenchymal Transition Proteins.

Authors:  Yuejun Tian; Ping Qi; Qian Niu; Xuemei Hu
Journal:  Front Mol Biosci       Date:  2020-02-28

5.  Y-box binding protein 1 augments sorafenib resistance via the PI3K/Akt signaling pathway in hepatocellular carcinoma.

Authors:  Ting Liu; Xiao-Li Xie; Xue Zhou; Sheng-Xiong Chen; Yi-Jun Wang; Lin-Ping Shi; Shu-Jia Chen; Yong-Juan Wang; Shu-Ling Wang; Jiu-Na Zhang; Shi-Ying Dou; Xiao-Yu Jiang; Ruo-Lin Cui; Hui-Qing Jiang
Journal:  World J Gastroenterol       Date:  2021-07-28       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.